Skip to main content
ACET
NASDAQ Life Sciences

FDA Clears Adicet's IND for ADI-212 in Prostate Cancer

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$8.97
Mkt Cap
$83.973M
52W Low
$6.01
52W High
$17.438
52W Position info
49% above low
Off High info
49% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ACET sits 49% above its 52-week low of $6.01.

Summary

Adicet Bio received FDA clearance to begin clinical trials for ADI-212, a gene-edited CAR T therapy for metastatic castration-resistant prostate cancer. The company plans to start Phase 1 enrollment in Q4 2026. This is a new pipeline asset for Adicet, which recently reported Q2 results and a timeline for its lead asset prula-cel. The IND clearance validates the company's expansion into solid tumors and adds a near-term clinical catalyst. Investors will watch for initial safety and efficacy data from the Phase 1 trial.

At the time of this announcement, ACET was trading at $8.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $84M. The 52-week trading range was $6.01 to $17.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

ACET - Latest Insights

ACET
Nov 05, 2026, 4:15 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.95
Real-time Price: $2.95 info
Change: $0 (0%) info
Market Cap: $27.336M info
ACET
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.95
Real-time Price: $2.95 info
Change: $0 (0%) info
Market Cap: $27.336M info
ACET
Sep 28, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.96
Real-time Price: $2.95 info
Change: -$6.01 (-67%) info
Market Cap: $27.336M info
ACET
Sep 28, 2026, 6:45 AM EDT
Source: BusinessWire
Importance Score:
9
Price at Filing: $9.99
Real-time Price: $2.95 info
Change: -$7.04 (-70%) info
Market Cap: $27.336M info
ACET
Sep 01, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.72
Real-time Price: $2.95 info
Change: -$5.77 (-66%) info
Market Cap: $27.336M info